| 1 |
24667336 | Molecular basis of the association of H208Y and thymidine analogue resistance mutations M41L, L210W and T215Y in the HIV-1 reverse transcriptase of treated patients. | 2014 Jun |
1 |
| 2 |
25397495 | Transmitted antiretroviral drug resistance mutations in newly diagnosed HIV-1 positive patients in Turkey. | 2014 |
1 |
| 3 |
22889300 | Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy. | 2012 Aug 13 |
1 |
| 4 |
23061604 | Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01_AE. | 2012 Dec |
1 |
| 5 |
21709569 | Drug resistance and viral tropism in HIV-1 subtype C-infected patients in KwaZulu-Natal, South Africa: implications for future treatment options. | 2011 Nov 1 |
1 |
| 6 |
19457988 | Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibility. | 2009 Aug |
1 |
| 7 |
19852859 | Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens. | 2009 Oct 25 |
1 |
| 8 |
16312176 | Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapy. | 2005 |
2 |